2022 BioInnovation Summit Postponement Notice

Dear Speakers, Invited Guests, Exhibitors and Sponsors,

In order to conform to the latest pandemic control policies in Hangzhou, the committee of 2022 BioInnovation Summit decides to postpone the Summit from December 3-4 to the spring of 2023. The new conference date will be announced in our official Wechat account and website once it's confirmed.

We hereby sincerely apologize for any inconvenience caused. As the Summit organizer, we would continue our efforts and try our best to deliver our after-postponement service. Thanks for your trust and understanding. 

See you next year in Hangzhou.


The Committee of 2022 BioInnovation Summit

November 29 2022   


Speakers
Guo-Liang Yu
Chairman and CEO of Apollomics
Yingfei Wei
Chairperson of BioInnovation Summit, Chairwoman of BioInnovation Institute.
Bruce Beutler

Director of Center for the Genetics of Host Defense, UT Southwestern, 2011 Nobel Laureate in Physiology or Medicine


Hank Wuh
Surgeon, Inventor and Investor, Trustee of the University of Hawaii Foundation
Lin Xu
Chairman and Partner of China-U.S. Green Fund
Weili Hong

Visiting Professor at School of Economics of Fudan University

Tianjin Xu
Professor at School of Archaeology and Museology of Peking University, Director of Liangzhu Museum (Liangzhu Institute) 
Kejian Huang

Founder of SinoType, Chairman and General Manager of Beijing SinoType Technology, Chief Multimedia Planner of Beijing Olympic Bid Committee Presentation Report

Yingxian Xiao
Dean of BioInnovation Institute
Yi-Wei Tang

Chief Medical Officer of Danaher Dx Platform/Cepheid China, Fellow of American Academy of Microbiology

Yao-Wei Huang
Professor in Department of Veterinary Medicine of Zhejiang University
Shibo Jiang
Director of Institute of Medical Microbiology in Fudan University, Fellow of American Academy of Microbiology
Jianwei Wang

Vice President of Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS/PUMC)

Ning Li
CEO of Shanghai Junshi Biosciences 
Shoubai Chao
COO of CanSinoBIO
Patrick Y. Lu

Chairman of the Board, Executive Director, President & CEO

Yuling Li

Co-founder and CEO of Innoforce Pharmaceuticals

Jin Liang
Managing Director of CICC
Peizhuo Zhang
Chairman of Suzhou GenePharma
Long-Cheng Li

Founder, Chairman and CEO of Ractigen Therapeutics

Jia Fei
Professor/Doctoral Supervisor of School of Basic Medicine in Jinan University, Director of Guangdong Engineering Research Center for Small RNA Drug Development
Yu Wu
Partner & Patent Attorney of JunHe
Yun Yang
CTO of Shanghai Circode Biomed  
Robert J. Lee
Chief Scientific Officer of Zhejiang Haichang Biotech Co., Ltd.
Dong Shen
Founder and CEO of RNAimmune 
Zihui Fang
Senior Scientist of Center for Excellence of Innoforce Pharmaceuticals 
Yuwen Liu
Founding Partner of BOHE Angel Fund
Lu Gao
CEO of Therorna Inc.
Dajie Tang

Chairman of Triwise Capital 

Guoping Zhao
Member of Chinese Academy of Sciences
Daniel Ramon Vidal
Member of Royal Academy of Engineering of Spain
Chenli Liu
Vice President of Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences
Lixin Zhang
Professor and Director of State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology
Enwei Xie

Partner of Transfar Innovation Polis Fund

Xibin Zhou
Co-founder, Chairman and General Manager of Synceres Biosciences
Baishan Fang

Director of Xiamen City Key Laboratory of Synthetic Biotechnology

Yiming Li

Professor at Southern University of Science and Technology, Co-founder and Chief Scientific Officer of Shengrui Biotech


Hui Zhu

Founder of NEWGEN BIO

Ran Chao
Co-founder and CEO of LifeFoundry
Ben Zhao

 Founder and President of Zhejiang Haichang Biotech Co., Ltd.


Gang Chen

CSO of R&G PharmaStudies

Juhong Liu

CEO of GlobalSubmissions Consulting

Hongliu Ding

VP of Pulmongene

Shen Xiao
Chief Strategy Officer of 3D Medicines
Yaning Wang

CEO of Createrna Science and Technology

Shichun Zhang
BD Director of Novotech Shanghai
Ruyi He
Chief Medical Officer of RemeGen, Chief Scientist of SDIC Fund Management CO., LTD
Xiao Xiao
Chairman and founder of Belief Biomed
Richard Wang
CEO and Founder of Neukio Biotherapeutics
Lin Yang

CEO and Founder of PersonGen

Claire Zhang

 CTO and Co-founder of Innostellar Biotherapeutics 

Grace Zhou
CEO and Chairman of ImmVira 
Tina Liu
Senior Associate of AllBright Law Offices
Al Lin

CEO of Innoland Biosciences (USA/China)

Fred Mao
Partner and Managing Director of Frost & Sullivan 
Min Zhu
Senior VP of CDMO Operations of Innoforce Pharmaceuticals
Ying Yang

Founder and General Manager of Lab-Direct

Guang Gao
Senior Technical Officer at PATH China Office, Former FDA Senior Reviewer
Weihua Song
VP of Innoland Biosciences
Qiming Wang
Director of Products and Services of The Jackson Laboratory China 
Jinsong Guo
Founder of DrugTimes, Co-Chairman and Secretary General of China Alliance for New Drug Development for Liver Diseases.
Long Zhang
Co-founder and President of MindRank AI in China
Fengfeng Xu
Executive Vice President of Abogenbio
Kelvin Shao
Vice General Manager of Kexing Biopharm Co., Ltd. 
William Haseltine

professor
Professor, Central Academy of Fine Arts

professor
Professor, Central Academy of Fine Arts

Agenda
  • Keynote Program
  • Session A
  • Session B
  • Session C
Keynote Program
December 3rd, 2022, Saturday
Hangzhou International Expo Center
Time
Speech
Speaker
08:30 - 09:00
Opening Ceremony
Reserve
Keynote Program
09:00 - 09:40
Fireside Chat: Immortality, the Ultimate Challenge of Life Science
Bruce Beutler, Hank Wuh
Reserve
09:40 - 10:20
Strategy for Life Science and Biotech Companies under New Challenges
Guo-Liang Yu
Reserve
10:20 - 10:30
Stay Younger, Happier and Healthier: Announcing Dr. Guo-Liang Yu's 2nd Book
Guo-Liang Yu
Reserve
10:30 - 10:45
Coffee Break
Reserve
10:45 - 11:25
What Are New Drivers of Economic Growth in China?
Lin Xu
Reserve
11:25 - 12:00
The New Frontier of PE/VC Market in China with a Global Perspective
Weili Hong
Reserve
12:20 - 13:20
Lunch Program: Information Design of Chinese Ideograph in the Context of Meta Universe
Kejian Huang
Reserve
A Long and Complicated Relationship of Humans and Viruses: Past, Present and Future.
14:00 - 14:30
The Past and the Present of Clinical Virology
Yi-Wei Tang
Reserve
14:30 - 15:00
The Current and Future of COVID-19 Vaccines
Shibo Jiang
Reserve
15:00 - 15:30
Emerging Animal Coronaviruses: Interspecies Transmission and Control
Yao-Wei Huang
Reserve
15:30 - 15:45
Coffee Break
Reserve
15:45 - 16:10
Virus Mutation and Responses: Challenges and Prospects
Jianwei Wang
Reserve
16:10 - 16:35
Progress in Antiviral Drugs
Ning Li
Reserve
16:35 - 17:00
Progress in Antiviral Vaccines
Shoubai Chao
Reserve
17:00
Closing
Reserve
17:00 - 19:00
Light Dinner
Reserve
19:00 - 20:30
BioInnovation Talent Show
Reserve
Session A
December 4th, 2022, Sunday
Hangzhou International Expo Center
Time
Speech
Speaker
RNA Era: Technologies, Products, Pain Points, Future.
09:00 - 09:10
Opening Remarks
Reserve
09:10 - 09:50
Small RNA-based Drugs Development and Manufacturing: Opportunities and Challenges
Peizhuo Zhang
Reserve
09:50 - 10:30
Touching the Void – Delivering Oligonucleotides to the CNS
Long-Cheng Li
Reserve
10:30 - 10:45
Coffee Break
Reserve
10:45 - 11:20
Introduction of a New Track for Developing Small Nucleic Acid Drugs Targeting miRNA in Non-coding RNA
Jia Fei
Reserve
11:20 - 12:00
mRNA Technologies: Opportunities and Challenges
Dong Shen
Reserve
12:20 - 13:20
Lunch Program: Archaeology, a Window to Know the World
Tianjin Xu
Reserve
14:00 - 14:35
Patent Landscape Surrounding LNP and Recent Cases
Yu Wu
Reserve
14:35 - 15:10
Develop Technology Platform for Circular RNA Therapies
Yun Yang
Reserve
15:10 - 15:45
QTsomes for Delivery of Nucleic Acid Therapeutics
Robert J. Lee
Reserve
15:45 - 16:00
Coffee Break
Reserve
16:00 - 16:30
The End-to-End CMC Development Strategies and Challenges for mRNA Vaccines/Drugs
Zihui Fang
Reserve
16:30 - 17:30
Panel Discussion: Innovation in mRNA era - Dialogue with Investors
Yuling Li, Jin Liang, Dong Shen, Peizhuo Zhang, Yu...
Reserve
17:30
Closing of Session A
Reserve
Session B
December 4th, 2022, Sunday
Hangzhou International Expo Center
Time
Speech
Speaker
Biosynthesis
09:00 - 09:05
Opening Remarks
Dajie Tang
Reserve
09:05 - 09:30
Biosynthesis and Biotechnology: from Creation for Use to Industrial Transformation
Guoping Zhao
Reserve
09:30 - 10:00
Postbiotics: Microbiome Modulators for the Future
Daniel Ramon Vidal
Reserve
10:00 - 10:30
Biosynthesis Industry: Present and Future
Chenli Liu
Reserve
10:30 - 10:45
Coffee Break
Reserve
10:45 - 11:05
From Discovery to Intelligent Manufacturing of Microbial Drugs
Lixin Zhang
Reserve
11:05 - 12:00
Panel Discussion: The New Frontier of Synthetic Biology
Enwei Xie, Xibin Zhou, Baishan Fang, Yiming Li, Hu...
Reserve
12:20 - 13:20
Lunch Program: Archaeology, a Window to Know the World
Tianjin Xu
Reserve
Winning at the Starting Line for Chinese Pharmaceutical Companies' Oversea Strategy - in light of the FDA New Policy
14:00 - 14:05
Opening Remarks
Ben Zhao
Reserve
14:05 - 14:30
Key Considerations for the Global Clinical Trial(MRCT) Design and Case Studies
Gang Chen
Reserve
14:30 - 14:55
Management of CMC Changes from Clinical to Commercial-Transition from Quality to Quantity
Juhong Liu
Reserve
14:55 - 15:20
Discussion on the Clinical Trial Strategy of Domestic Innovative Pharmaceutical Companies Applying for Drug Registration both in China and the United States
Hongliu Ding
Reserve
15:20 - 15:45
Drug Development Strategies based on New Clinical Value Guidelines
Shen Xiao
Reserve
15:45 - 16:00
Coffee Break
Reserve
16:00 - 16:25
The Impact of FDA Optimus and Equity Projects on Global Oncology New Drug Development
Yaning Wang
Reserve
16:25 - 16:50
Simultaneous Global Development of China-originated Innovative Drugs
Shichun Zhang
Reserve
16:50 - 17:30
Panel Discussion: The Dawn of Chinese Innovative Biopharma Going Global
Ben Zhao, Ruyi He, Ning Li, Gang Chen, Shen Xiao,...
Reserve
17:30
Closing of Session B
Reserve
Session C
December 4th, 2022, Sunday
Hangzhou International Expo Center
Time
Speech
Speaker
Cell Gene Therapy: How to Do Better
09:00 - 09:05
Opening Remarks
Yuling Li
Reserve
09:05 - 09:30
Overview of Gene Therapy and its Development in China
Xiao Xiao
Reserve
09:30 - 10:00
Driving Next Generation Cell Therapy with iPSC-CAR-NK
Richard Wang
Reserve
10:00 - 10:30
The Latest Progress and Trend of Global CAR-T Cell Therapy for Solid Tumor
Lin Yang
Reserve
10:30 - 10:45
Coffee Break
Reserve
10:45 - 11:10
AAV-based Gene Therapies: CMC Development and IND Filing
Claire Zhang
Reserve
11:10 - 11:35
The Challenge and Breakthrough of Oncolytic Virus
Grace Zhou
Reserve
11:35 - 12:00
Cell and Gene Therapy Regulation and Pre-IPO Compliance Strategies in China and the United States
Tina Liu
Reserve
12:20 - 13:20
Lunch Program: Archaeology, a Window to Know the World
Tianjin Xu
Reserve
CXO (CRO, CDMO, CPO): “Silk Road Stations" for Innovative Drug R&D
14:00 - 14:15
Paradigm Shift in Biopharma Industry and the Prospect of CXOs: Building“Silk Road Stations" for Innovative Drug R&D
Al Lin
Reserve
14:15 - 14:45
Overview of CXO Business in China
Fred Mao
Reserve
14:45 - 15:05
Be a Proud CDMO that Enables New Drug Development
Min Zhu
Reserve
15:05 - 15:25
CPO (Contract Procurement Organization): SPM Supply Chain Builds a Highway" for Biomedical Industry
Ying Yang
Reserve
15:25 - 15:45
Global Regulation Road Map on ATMP Products Regulatory CMC- A Road Map for a Successful Journey
Guang Gao
Reserve
15:45 - 16:00
Coffee Break
Reserve
16:00 - 16:20
Innovative Mouse Models to Empower Drug Discovery
Qiming Wang
Reserve
16:20 - 16:40
Role of NHPs in Biopharma Research
Weihua Song
Reserve
16:40 - 17:30
Panel Discussion: Your Dream CXO Partner - a Sponsors’Perspective
Jinsong Guo, Al Lin, Long Zhang, Fengfeng Xu, Kelv...
Reserve
17:30
Closing of Session C
Reserve
Live Stream
Keynote
Session A
Session B
Session C
Tel:0571-82816999 Website:www.bioinnovation-summit.com Mailbox:bioinnovation@innoforcepharma.com

Copyright © 2019-2022 BioInnovation Summit All Rights Reserved 浙公网安备33010902003140号 浙ICP备20024304号-1. Designed by Wanhu.